Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of PolyOne (NYSE: POL ) jumped 10% today after the company reported earnings.
So what: First quarter revenue was up 7.5% to $801.1 million and adjusted earnings per share rose 29% to $0.31. Analysts expected higher revenue of $817.1 million but only $0.26 in earnings per share so the bottom line is what investors are excited about today. �
Now what: The specialty business drove earnings on a 34.4 increase in operating income. There is clearly a lot of momentum in the business because this is the 14th consecutive quarter of double-digit, adjusted-earnings-per-share growth. The stock trades at just 14 times forward estimates, which is an attractive price considering the continued growth and I think shares can move higher long term.
Interested in more info on PolyOne? Add it to your watchlist by clicking here.
Top 10 Promising Stocks To Buy Right Now: Danieli & C Officine Meccaniche SpA (DAS)
Danieli & C Officine Meccaniche SpA is an Italy-based company primarily engaged in industrial sector. The Company designs, manufactures, sales and makes installation of machines and plants for the metallurgical industry. The Company's portfolio includes mines; pellet production plants; blast furnaces; direct reduction equipment; machinery for the treatment of scrap metal; steelworks for production of liquid steel; continuous casting machinery for blooms, billets and slabs; rolling mills for long products, seamless tubes and flat products; production lines for welded tubes and flat products; plants for secondary processing, such as peeling, rolling and drawing; forging presses and manipulators; extrusion presses for ferrous and non-ferrous metals; plants for longitudinal and transversal cutting; automation and control systems, and cranes and lifting equipment. It is also active in the production and sale of special steel for automotive, machine tools and railway industry, among others. Advisors' Opinion:- [By GURUFOCUS]
EMC�� products ��both hardware and software - are litearlly a geek�� wonderland alphabet soup, which include Storage Area Network (SAN), Network Attached Storage (NAS), Direct Attached Storage (DAS), Virtual SAN, All-Flash XtremIO, Atmos, Avamar, �Data Domain, Isilon, Pivotal, ViPR Software Defined Storgae, VMAX, VNX, VNXe, VPLEX, VSPEX (none of these are typos).� Information storage makes up 70% of revenues and virtualization 23% of revenues.� Products generate 55% of revenues.� Services generate 45% of revenues.� The Company�� gross profit split is approximaltey 67% data storage and 31% virtualization.
- [By Damian Illia]
Crown Castle has acquired recently the privately held company NextG Networks Inc., largest provider of outdoor Distributed Antenna Systems (DAS), with more than 7,000 DAS plus another 1,500 nodes in the pipeline, and over 4,600 miles fiber-optic cable�� transmission rights. Through this addition, the company has improved greatly its DAS network across 26 United States metropolitan areas. As NextG has only 1.7 tenants per network on an average and thus underutilizing its capacity, Crown Castle will increase customers with no integration and rearrangement costs. Another company�� big move was the acquisition of 9,700 wireless towers from AT&T Inc. (T) Located in the top 100 markets in the U. S. T-Mobile is likely to maintain its infrastructure in these towers for the next 10 years. On top of all, the recent conversion of business into a REIT has represented long term benefits for the company in terms of tax savings and enhancing shareholders��wealth.
Hot Long Term Stocks To Invest In 2014: Steven Madden Ltd.(SHOO)
Steven Madden, Ltd., together with its subsidiaries, designs, sources, markets, and sells fashion-forward name brand and private label footwear for women, men, and children. It offers wholesale footwear under the Steve Madden Women?s, Madden Girl, Steve Madden Men?s, Steven, l.e.i., Elizabeth and James, Olsenboye, Stevies, Big Buddha Shoes, Madden, Betsey Johnson shoes, Report, and Superga to department stores, mid-tier department stores, better specialty stores, and independently owned boutiques in the United States. The company also provides wholesale handbags and accessories under the Daisy Fuentes, Olsenboye, Steve Madden, Steven by Steve Madden, Betsey Johnson, Betseyville, and Big Buddha brand names, as well as sells cold weather accessories, fashion scarves, wraps, and other trend accessories primarily under the Cejon and Steve Madden brand names to department stores and specialty stores. As of December 31, 2011, it operated 84 retail stores, including 73 Steve Ma dden full price stores, 6 Steve Madden outlet stores, 3 Steven stores, 1 Report store, and 1 e-commerce Website. In addition, the company licenses its Steve Madden and Steven by Steve Madden trademarks for use in connection with the manufacturing, marketing, and sale of cold weather accessories, sunglasses, eyewear, outerwear, bedding, hosiery and women?s fashion apparel, jewelry, and luggage, as well as licenses Betsey Johnson and Betseyville trademarks for sale of apparel, jewelry, swimwear, eyewear, watches, fragrances, and outerwear. Steven Madden, Ltd. distributes its products through its retail stores and e-commerce Website in department stores, specialty stores, luxury retailers, national chains, and mass merchants in the United States; and through special distribution arrangements in Asia, Canada, Europe, the Middle East, Mexico, Australia, Central and South America, and India. The company was founded in 1990 and is headquartered in Long Island City, New York.
Advisors' Opinion:- [By Ben Levisohn]
Shares of Deckers Outdoor have dropped 13% to $73.90, while Crocs (CROX) has gained 0.8% to $15.24, Steve Madden (SHOO) has dropped 0.1% to $36.52, Wolverine World Wide (WWW) has fallen 1.2% to $126.36 and Skechers (SKX) has fallen 1.6% to $33.82.
Hot Long Term Stocks To Invest In 2014: Wynn Macau Ltd (WYNMF)
Wynn Macau, Limited is a holding company. The Company, along with its subsidiaries, is a developer, owner and operator of destination casino gaming and entertainment resort facilities in Macau. Its operating subsidiary, Wynn Resorts (Macau) S.A. (WRM), owns and operates destination casino resort Wynn Macau in Macau. As of December 31, 2011, it had 265,000 square feet of casino space, offering 24-hour gaming with a range of games, and two luxury hotel towers with 1,008 spacious rooms and suites. It also offers eight casual and fine dining restaurants, 54200 square feet of stores and boutiques, such as Bvlgari, Chanel, Dior, Gucci, Hermes, Hugo Boss, Louis Vuitton, Miu Miu, Piaget, Prada, Rolex, Tiffany, Vacheron Constantin, Van Cleef & Arpels, Versace, Vertu and others, two health clubs and spas, a salon, a pool, and lounges and meeting facilities. As of December 31, 2011, its subsidiaries included Wynn Resorts International, Ltd., Wynn Resorts (Macau) Holdings, Ltd. and others. Advisors' Opinion:- [By MARKETWATCH]
HONG KONG (MarketWatch) -- Hong Kong stocks sold off early Thursday after the Federal Reserve decided to further taper stimulus, and after a final reading of China's manufacturing PMI contracted. The Hang Seng Index (HK:HSI) sank 1.5% to 21,815.04 in holiday-shortened trading. Tech stocks retreated, as Chinese PC maker Lenovo Group Ltd. (HK:992) (LNVGF) dropped 5.3%, failing to get a lift from news that it plans to acquire the Motorola handset business from Google Inc. (GOOG) for $2.91 billion as Lenovo aims for a bigger presence in the U.S. market. Software developer Kingsoft Corp. (HK:3888) (KSFTF) fell 1.9% and Internet giant Tencent Holdings Ltd. (HK:700) (TCTZF) dropped 1.5%. Casino stocks also declined. Sands China Ltds. (HK:1928) (SCHYF) , the Hong Kong-listed unit of Las Vegas Sands Corp. (LVS) , slipped 0.2%, despite financial results that showed Sands China's net income increased 40% year-on-year to $467 million in the fourth quarter. Melco Crown Entertainment Ltd. (HK:6883) (MPEL) slumped 3.2%, and both Wynn Macau Ltd. (HK:1128) (WYNMF) and MGM China Holdings Ltd. (HK:2282)
Hot Long Term Stocks To Invest In 2014: Anacor Pharmaceuticals Inc. (ANAC)
Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company�s lead product candidates include tavaborole, an antifungal product candidate that is in Phase III clinical development for the treatment of onychomycosis; and AN2728, an anti-inflammatory product candidate, which completed Phase II clinical trials for the treatment of atopic dermatitis and psoriasis. It also develops AN5568, a Phase I human clinical trial product targeting human African trypanosomiasis; and other compounds to treat animal health indications. The company�s clinical pipeline also includes AN2718, a topical antifungal product candidate, which is in Phase I clinical trials for the treatment of onychomycosis and fungal infections of the skin; AN2898, a topical anti-inflammatory product candidate that completed the Phase IIa clinical trials for the treatment of atopic dermatitis and psoriasis; and AN3365, an antibiotic for the treatment of infections caused by Gram-negative bacteria. It has research, development, and collaboration agreements with GlaxoSmithKline LLC, Eli Lilly and Company, Medicis Pharmaceutical Corporation, and Medicines for Malaria Ventures. The company was formerly known as AnaMax, Inc. and changed its name to Anacor Pharmaceuticals, Inc. in October 2002. Anacor Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Palo Alto, California.
Advisors' Opinion:- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Anacor Pharmaceuticals Inc.(ANAC) swung to a profit in the fourth quarter, driven by gains from a litigation settlement and a rise in revenue. The company’s revenue beat market expectations. Shares rose 6.4% to $21.45 in light premarket trading.
- [By Grace L. Williams]
Honorable mentions go out to Coronado Biosciences (CNDO), after its CEO Harlan Weisman and Jay Lobell, a longtime director, joined forces and bought 20,000 shares for $152,100; and to Anacor Pharmaceuticals (ANAC) after CFO Geoffrey Parker bought 33,000 shares for $224,300. InsiderScore noted that Parker�� purchase was his largest to date and called it a ��ompelling positive event.��/p>
Hot Long Term Stocks To Invest In 2014: Endologix Inc(ELGX)
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of aortic disorders. It offers the ELG System, a stent graft and delivery system for the treatment of abdominal aortic aneurysms through minimally-invasive endovascular repair. The company also provides aortic extensions and limb extensions, which attach to the main body of ELG Device, enabling physicians to customize it to fit the patient?s anatomy. In addition, it offers accessories, such as guidewires, snares, and catheter introducer sheaths that facilitate the optimal delivery of its ELG Device. Endologix, Inc. sells its products through direct sales force and independent distributors in the United States, Europe, Asia, South America, and Mexico. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Endologix (Nasdaq: ELGX ) , whose recent revenue and earnings are plotted below. - [By DailyFinance Staff]
Concerns about the political uncertainty in Ukraine caused some volatility in the markets Friday afternoon, with the major indexes making several U-turns ahead of the weekend. The Dow Jones industrial average (^DJI), which had been up by as much as 125 points, briefly dropped into loss territory before rebounding to end 49 points higher. The Standard & Poor's 500 index (^GPSC) edged up 5 points, adding to Thursday's record high, but the Nasdaq composite (^IXIC) lost 10 points. AP/Darko VojinovicPro-Russian militias have seized local government buildings in Crimea, Ukraine; the unrest there is making investors around the world nervous. February was a great month for investors. All three major averages jumped by about 4 percent. UnitedHealth Group (UNH) led the blue chips, gaining 1½ percent. Other health providers – Aetna (AET), Wellpoint (WLP), Cigna (CI) and Humana (HUM) -- all gained between 1½ and 2 percent. And retail stocks remained active. Target (TGT) added another 3 percent. Best Buy rose 4 percent, and Fred's (FRED), a regional department store chain, jumped 10 percent. But Pier 1 (PIR) fell 5½ percent after lowering its earnings outlook for a second time. That led to a series of brokerage downgrades. Decker Outdoor (DECK) tumbled 12 percent. The maker of footwear brands such as Ugg and Teva issued a weak outlook. And apparel maker Lululemon (LULU) fell 5-percent on negative comments from Credit Suisse. It seems as though there are always some big movers in the drug and biotech sectors – and that was certainly the case today. GW Pharmaceuticals (GWPH) rose 2 percent after the FDA granted orphan status to its drug to treat a rare form of childhood epilepsy. But most of the action was on the downside. Endologix (ELGX) slid 24 percent after forecasting lower revenue growth. Questcor (QCOR) fell 10 percent. It's lost big for three straight days amid allegations of questionable business practices. Jazz Pharma
- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Endologix (NASDAQ: ELGX) were down 23.48 percent to $13.68 on lowered guidance, analyst downgrades. Oppenheimer downgraded the stock from Outperform to Market Perform and cut the price target from $20.00 to $16.00. - [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of Endologix (NASDAQ: ELGX) were down 24.85 percent to $13.43 on lowered guidance, analyst downgrades. Oppenheimer downgraded the stock from Outperform to Market Perform and cut the price target from $20.00 to $16.00.
No comments:
Post a Comment